2027 Healthcare Provider Leads Side effects 
Pharmaceutical Technology
NOVEMBER 30, 2022
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field.
Pharmaceutical Technology
NOVEMBER 30, 2022
In the US, obesity care is estimated at to cost $147 billion in healthcare spending annually. In the past, obesity medications were often dismissed due to insufficient efficacy data and the fact that they were associated with a high occurrence of side effects. Novo Nordisk is another company leading the charge in this field.
Expert insights. Personalized for you.
105 
Let's personalize your content